National Jewish Health announced a new preferred provider of cardiopulmonary diagnostic instrumentation. MGC Diagnostics will deliver cardiorespiratory devices to the hospital’s main campus, including body plethysmography, gas exchange and spirometer systems.
“MGC Diagnostics is pleased to have been selected by National Jewish Health, one of the world’s leading medical research and treatment centers,” said Gregg O. Lehman, Ph.D., chief executive officer and president of MGC Diagnostics.
“We believe this win validates our technical innovation in cardiorespiratory health and our ability to provide leading medical facilities seamless communications with electronic medical records critical to improved workflows. We are excited to provide long term solutions that will assist them in maintaining their market leading status in respiratory care.”
National Jewish Health has been ranked by U.S.News & World Report as the number one pulmonology hospital in the nation for the past 15 consecutive years. Founded in 1899 as a nonprofit hospital, National Jewish Health remains the only facility in the world dedicated exclusively to these disorders.
